Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cel-Sci Corp (NY: CVM ) 1.085 UNCHANGED Streaming Delayed Price Updated: 8:00 PM EDT, Aug 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cel-Sci Corp < Previous 1 2 3 4 5 6 Next > Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session December 04, 2023 Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session December 04, 2023 Via Benzinga Why Is Cancer Focused CEL-SCI Stock Trading Higher Today? December 04, 2023 CEL-SCI Corporation (AMEX: CVM) announced that the British National Institute for Health and Care Excellence (NICE) has selected Multikine (Leukocyte Interleukin, Injection) to be evaluated as the... Via Benzinga Why CEL-SCI (CVM) Shares Are Down 20% July 18, 2023 CEL-SCI Corporation (NASDAQ: CVM) shares are trading lower by 21.3% to $2.25 Tuesday morning after the company priced its public offering of 2.5 million shares at $2.00 per share. Via Benzinga UK’S National Institute for Health and Care Excellence (NICE) Selects CEL-SCI’s Multikine as Potential New Standard of Care for Head & Neck Cancer December 04, 2023 From CEL-SCI Corporation Via Business Wire CEL-SCI Announces Closing of $5 Million Public Offering of Common Stock November 20, 2023 From CEL-SCI Corporation Via Business Wire CEL-SCI Announces Pricing of $5 Million Offering of Common Stock November 16, 2023 From CEL-SCI Corporation Via Business Wire CEL-SCI Issues Letter to Shareholders October 30, 2023 From CEL-SCI Corporation Via Business Wire Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments October 24, 2023 EQNX::TICKER_START (NASDAQ:TCBP),(NYSE:CVM),(NASDAQ:INVO),(NASDAQ:SNY),(NYSE:PFE) EQNX::TICKER_END Via FinancialNewsMedia Exposures Product Safety CEL-SCI Releases Video Detailing Recent Phase 3 Findings & its Plans to Seek Immediate Regulatory Approvals October 24, 2023 From CEL-SCI Corporation Via Business Wire 5-Year Head & Neck Cancer Survival Increased From 45% to 73% in CEL-SCI’s Target Population, Cutting Risk of Death in Half, as Presented at Leading Cancer Conference ESMO 2023 October 23, 2023 From CEL-SCI Corporation Via Business Wire CEL-SCI Readies Its Multikine Manufacturing Facility for Commercial Scale Production October 19, 2023 From CEL-SCI Corporation Via Business Wire CEL-SCI Files Request With the UK’s MHRA Regarding Path to Approval for Multikine in the Treatment of Head & Neck Cancer October 05, 2023 From CEL-SCI Corporation Via Business Wire CEL-SCI Submits Scientific Advice Filing to European Medicines Agency (EMA) for Multikine in the Treatment of Head & Neck Cancer September 26, 2023 From CEL-SCI Corporation Via Business Wire CEL-SCI Corporation Reports Third Quarter Fiscal 2023 Financial Results August 11, 2023 From CEL-SCI Corporation Via Business Wire Stocks That Hit 52-Week Lows On Monday July 31, 2023 On Monday, 27 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday July 28, 2023 Friday's session saw 59 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday July 25, 2023 On Tuesday, 56 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Monday July 24, 2023 On Monday morning, 70 companies achieved new lows for the year. Via Benzinga CEL-SCI Announces Closing of Public Offering July 20, 2023 From CEL-SCI Corporation Via Business Wire 12 Health Care Stocks Moving In Tuesday's Intraday Session July 18, 2023 Via Benzinga Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 18, 2023 Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring. Via Benzinga US Stocks Mixed; Bank of America Tops Q2 Views July 18, 2023 U.S. stocks traded mixed this morning, with the Dow Jones gaining around 70 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.20% to 34,655.10 while the NASDAQ fell 0.38% to... Via Benzinga TDOC Stock Alert: Teladoc Doubles Down on Microsoft AI Partnership July 18, 2023 Teladoc (TDOC) stock is on the move Tuesday as the company expands its Microsoft (MSFT) AI partnership to enhance Teladoc Health Solo. Via InvestorPlace CMG Stock Alert: Chipotle Announces International Expansion Plan July 18, 2023 Chipotle Mexican Grill (CMG) stock is in the news Tuesday after the restaurant chain announced plans for an international expansion. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Pre-Market Session July 18, 2023 Via Benzinga Why Is CEL-SCI (CVM) Stock Down 23% Today? July 18, 2023 CEL-SCI (CVM) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering. Via InvestorPlace Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket July 18, 2023 Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday July 18, 2023 It's time to start off trading for Tuesday with a breakdown of the biggest pre-market stock movers worth watching this morning. Via InvestorPlace CEL-SCI Announces Pricing of Public Offering July 17, 2023 From CEL-SCI Corporation Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.